July 25th 2024
Insights from Takeda, Jazz, Nestlé Health Sciences, Humana, and other healthcare executives
Engaging with Stakeholders In the Information Age
May 23rd 2018With so much information readily available companies have lost a significant level of control over how and when details about their progress in drug development and planning related to approval, launch, and commercialization are disseminated.
The UK's Post-Brexit Life Sciences Strategy: Outlook and Implications
September 5th 2017Following the unveiling of the UK’s post-Brexit life sciences strategy, Neil Grubert looks at the measures related to market access, a particular challenge in the UK market and key to its future success in the sector.